Join Phunware to explore how connected health will create new opportunities for engaging with patients before, during and after hospital visits.
Value is a concept that concerns all healthcare stakeholders.
Briefing materials released before Wednesday's panel review indicate the regulator wants clearer data to assess Amgen's experimental melanoma treatment.
We know it's early days (the smartwatch been available for three days to be exact), but we'd like to know how it is going.
The Centers for Medicare and Medicaid Services last year published 4.45 million records about financial relationships between industry and HCPs.
More pharma companies hike drug prices post-acquisition; HCV linked to increased risk of cancer; a combined Teva-Mylan would control 25% of the US generic drug market
Fueled by breakthrough drugs that actually broke through, spending on pharma products surged an incredible 13.1% in 2014, a figure that stunned even the sunniest of optimists. But with some of the contributing factors looking like one-time-only events, pundits wonder if perhaps the gains have been overstated—and don't get them started on the threat posed by payers pushing back against drug prices. Look for profiles of the 2015 top 20 pharma firms tomorrow, listed in order based on total US sales in 2014, plus a wealth of tabulated data
Session: Battle of the Big Idea
The Healthcare Businesswoman's Association 2015 Honorable Mentor has elevated mentoring to a prominent place.
The drugmaker said its top-selling multiple-sclerosis drug Tecfidera's slowdown in sales is due to competition from Plegridy as well as new patient concerns about risks of a rare brain infection.
Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.